3/9/2023

Duloxetine Delayed Release Sprinkle Capsules

Products Affected - Description

- Drizalma Sprinkle oral delayed release capsule, Sun Pharma, 20 mg, bottle, 30 count, NDC 47335-0616-30
- Drizalma Sprinkle oral delayed release capsule, Sun Pharma, 30 mg, bottle, 30 count, NDC 47335-0617-30
- Drizalma Sprinkle oral delayed release capsule, Sun Pharma, 40 mg, bottle, 30 count, NDC 47335-0618-30
- Drizalma Sprinkle oral delayed release capsule, Sun Pharma, 60 mg, bottle, 30 count, NDC 47335-0619-30

Reason for the Shortage

- Sun Pharma is not currently producing Drizalma Sprinkle capsules due to regulatory issues.
- Sun Pharma is the sole supplier of duloxetine sprinkle capsules.
- Other duloxetine delayed-release capsules are not affected by this shortage.

Available Products

- There are no presentations available

Estimated Resupply Dates

- Sun Pharma has Drizalma Sprinkle capsules temporarily unavailable and the company cannot estimate when product will be available.

Updated

Updated March 9, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created July 11, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.